Evidence-Based Treatments for GI and Liver Disorders Powered by Extensive Research and Clinical Trials

Research is uncovering earlier means of diagnosing HCV infection, which together with emerging drug regimens is critical for avoiding cirrhosis and liver cancer. The development of new diagnostic assays that can detect pancreatic cancer earlier will undermine the disease’s lethality. Unwrapping the genetic foundations of nonalcoholic fatty liver disease promises targeted medicine for those at risk. Highly specific molecular probes in combination with novel optical imaging instrumentation